Jamie Elmawieh: Prophylactic Anticoagulation Improves Survival in Isolated Tumor Thrombus
Jamie Elmawieh, Anesthetist at Gustave Roussy Institute, shared a post on LinkedIn about a recent article he and her colleagues co-authored, published in Research and Practice in Thrombosis and Haemostasis, adding:
“New Insights in Cancer Associated Thrombosis and Isolated Tumor Thrombus:
Managing an isolated tumor thrombus (TT)—an intravascular extension of solid tumors rather than a classic blood clot—has long been a clinical grey zone. Because these masses are primarily composed of cancer cells, the role of anticoagulation has remained highly controversial and empirically driven.
A pioneering retrospective cohort study led by specialists from Gustave Roussy
(Loula Papageorgiou, Jamie Elmawieh, Paul Beunon, Salim Idelcadi and Corinne Frere), recently published in Research and Practice in Thrombosis and Haemostasis (RPTH), provides landmark data on this challenge.
Key takeaways from the study include:
- Significant Survival Benefit: Patients receiving prophylactic anticoagulation showed a dramatically higher restricted mean overall survival of 50.7 months, compared to only 20.8 months for those under observation alone (no anticoagulation).
- Favorable Safety Profile: Prophylactic intervention did not significantly increase major bleeding events or subsequent “bland” (classic) thromboembolic recurrences compared to the non-anticoagulated group.
While tumor thrombi do not respond to anticoagulants in the same way classic fibrin clots do, these findings suggest that prophylactic anticoagulation plays a crucial role in altering the clinical trajectory and survival outcomes of these complex oncological patients.”
Title: Prophylactic anticoagulation in isolated tumor thrombus: a single-center retrospective cohort study
Authors: Loula Papageorgiou, Jamie Elmawieh, Paul Beunon, Fehmi El Karoui, Salim Idelcadi, Florian Scotté, Corinne Frère
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 13, 2026, 15:51Merel Timmer: Hemophilia Twinning Partnership Strengthens Care and Quality of Life in Indonesia
-
Oct 13, 2026, 15:41Sarah Alam: ASH 2026 Guidelines on Iron Deficiency Diagnosis and Updated Ferritin Thresholds
-
Oct 13, 2026, 15:30Sally Mandour: Methemoglobinemia When Hemoglobin Cannot Carry Oxygen
-
Oct 13, 2026, 15:21Renel Tique: Advancing Hemophilia Care Through Global Collaboration and Clinical Innovation
-
Oct 13, 2026, 15:08Anastasia Chatzistamati: Unilateral Adrenal Haemorrhage in Primary Antiphospholipid Syndrome
-
Oct 13, 2026, 15:08Yousma Khan: Hematology Practical Series Day 11 Reticulocyte Count and Its Role in Anemia Diagnosis
-
Oct 13, 2026, 14:56Manal Rayyan: Multidisciplinary Collaboration in Rare Bleeding Disorders – Reflections from Abu Dhabi
-
Oct 13, 2026, 14:54Kalyan Roy: Understanding Blood Transfusion Sets for Safe Clinical Administration
-
Oct 13, 2026, 14:52Chedia Aroua: When Pharmacokinetics Meets Geophysics – Finding Unlikely Connections in Hemophilia Care